RPL31 and breast cancer: The protein level was four-fold higher in JL-DCIS-3 relative to non-diseased JL-Contra-3 (Table 1) and 1.5-fold higher in stage IV, while the gene expression level of Rpl31 was expressed highly in early and late-stage BC compared with non-diseased cells.